Source:http://linkedlifedata.com/resource/pubmed/id/12683722
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2003-4-9
|
pubmed:abstractText |
N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer platinates were prepared from polymeric intermediates containing Gly-Phe-Leu-Gly side chains terminating in either malonate or aspartate dicarboxylato ligands. Platinum(II) was bound by reaction of the dicarboxylato ligands with cis-[Pt(NH3)2(H2O)2]2+. The HPMA copolymer platinates obtained had a Mw of 29,000-31,000 Da and a platinum loading of approximately 10wt% (by AAS). This is close to the theoretical maximum value. The release rate of platinum species in vitro at pH 7.4 correlated with the expected stability of the 6 and 7 membered chelate rings; 14%/24 h platinum released in the case of the malonate and 68%/24 h platinum released in the case of the aspartate. Cisplatin and the aspartate conjugate displayed similar toxicity in vitro against B16F10 and COR-L23 cells while the malonate was at least 8-fold less toxic. The malonate conjugate showed significantly improved activity (T/C = 1.27-1.5) when compared with cisplatin (T/C = 1.18) that was not active when administered intravenously to treat a subcutaneous B16F10 tumour. The conjugate was at least 20-fold less toxic than cisplatin in vivo. After i.v. administration, the platinum accumulation in B16F10 tumour tissue showed a 19-fold increase in Pt AUC for the malonate conjugate when compared to cisplatin administered equi-dose at its maximum tolerated dose (MTD) (1 mg/kg).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Dicarboxylic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Methacrylates,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/hydroxypropyl methacrylate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1061-186X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
549-56
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12683722-Animals,
pubmed-meshheading:12683722-Area Under Curve,
pubmed-meshheading:12683722-Cell Line,
pubmed-meshheading:12683722-Chromatography, Gel,
pubmed-meshheading:12683722-Dicarboxylic Acids,
pubmed-meshheading:12683722-Hydrogen-Ion Concentration,
pubmed-meshheading:12683722-Ligands,
pubmed-meshheading:12683722-Male,
pubmed-meshheading:12683722-Melanoma, Experimental,
pubmed-meshheading:12683722-Methacrylates,
pubmed-meshheading:12683722-Mice,
pubmed-meshheading:12683722-Mice, Inbred C57BL,
pubmed-meshheading:12683722-Molecular Weight,
pubmed-meshheading:12683722-Organoplatinum Compounds
|
pubmed:year |
2002
|
pubmed:articleTitle |
HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation.
|
pubmed:affiliation |
Centre for Polymer Therapeutics, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|